BRAF inhibitors have been shown to activate the Sonic Hedgehog Homolog pathway in melanoma, which in turn will upregulate PDGFRα, leading to the development of resistance to the inhibitor [63]. The gene discussed is PDGFRA; the disease is melanoma.